EUVIMEDEUVIMED entdecken
Crossref

Dual-action antibacterial and anticancer agents: Design, synthesis, and mechanistic investigation of novel 4H-pyran–pyrazole hybrids

Salwa Aljohani, Sara Alaa Eldin Zaki, Asma Obaidallah Alatawi, Rasha Jame, Amenah S Al-Otaibi, Aljazi Abdullah AlRashidi, Ahmed A Elhenawy, Zienab E Eldin, Ahmed M El-Agrody, Heba K Abd El-Mawgoud, Walid E Elgammal

Bioorganic Chemistry · 2026-11 · 183 · 110583

DOI: 10.1016/j.bioorg.2026.110583 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-11. Verfasst von Salwa Aljohani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Science, Taibah University, Madinah, Saudi Arabia. Hauptthemen laut MEDLINE: Antineoplastic Agents, Anti-Bacterial Agents, Pyrazoles, Drug Design. Die Arbeit nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study involved the design, synthesis, and comprehensive biological evaluation of a new library of 4H-pyran-pyrazole hybrid molecules. The compounds were synthesized via versatile multicomponent and cyclocondensation reactions and characterized using spectroscopic techniques. Their biological potential was assessed through a multifaceted in vitro approach. Cytotoxicity screening against MDA-MB-415, MCF-7, and HepG2 cancer cell lines and normal cells HFL-1 and WI-38 revealed moderate and weak dose-dependent effects. Notably, derivatives 13a and 13d exhibited superior potency against MCF-7 breast cancer cells (IC₅₀ = 66.70 and 105.91 μM, respectively), outperforming the standard drug Tamoxifen. Antimicrobial evaluation identified compounds 4 and 11 as standout leads. Compound 11 demonstrated broad-spectrum bactericidal activity against Gram-positive pathogens, potent inhibition of S. aureus biofilm formation at sub-MIC concentrations (74.2% reduction at ½ MIC), and favorable killing kinetics. Conversely, the parent scaffold 4 was highly effective against Gram-negative E. coli and was identified as a potent dual inhibitor of bacterial DNA gyrase (IC₅₀ = 67.51 μM) and topoisomerase IV (IC₅₀ = 74 μM). Antifungal activity revealed a divergent structure-activity relationship, with the lipophilic tricyclic derivative 9 emerging as a potent fungicidal agent. Molecular docking studies against P-glycoprotein and the S. aureus choline-binding domain provided rational structural insights into the observed antitumor and antimicrobial activities, highlighting key interactions for target engagement. The results establish a clear structure-activity relationship and identify 11 as a promising multi-action lead compound, combining potent bactericidal and antibiofilm activities, thereby offering a robust foundation for developing new anticancer and antimicrobial agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsAnti-Bacterial AgentsPyrazolesDrug DesignPyransHumansMicrobial Sensitivity TestsStructure-Activity RelationshipDrug Screening Assays, AntitumorMolecular StructureDose-Response Relationship, DrugCell Line, TumorCell ProliferationMolecular Docking SimulationStaphylococcus aureusEscherichia coliGram-Positive Bacteria

Stichwörter der Autor:innen

4H-Pyran–pyrazole hybridsAntibacterialAntifungalMBCMFCMICMolecular dockingcancer cell lines

Substanzen

Antineoplastic AgentsAnti-Bacterial AgentsPyrazolesPyrans

Autor:innen und Institutionen

  • Department of Chemistry, College of Science, Taibah University, Madinah, Saudi Arabia.
  • Chemistry Department, Faculty of Women for Arts, Science, and Education, Ain Shams University, Cairo, Egypt.
  • Department of Chemistry, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia.
  • Department of Chemistry, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia. Electronic address: rjame@ut.edu.sa.
  • Department of Biology, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia.
  • Chemistry Department, Faculty of Science, University of Ha'il, Ha'il, 81451, Saudi Arabia.

Zitieren

APA

Aljohani, S., Zaki, S. A. E., Alatawi, A. O., Jame, R., Al-Otaibi, A. S., AlRashidi, A. A., Elhenawy, A. A., Eldin, Z. E., El-Agrody, A. M., Abd El-Mawgoud, H. K., & Elgammal, W. E. (2026). Dual-action antibacterial and anticancer agents: Design, synthesis, and mechanistic investigation of novel 4H-pyran–pyrazole hybrids. Bioorganic Chemistry, 183, 110583. https://doi.org/10.1016/j.bioorg.2026.110583

Vancouver

Aljohani S, Zaki SAE, Alatawi AO, Jame R, Al-Otaibi AS, AlRashidi AA, et al. Dual-action antibacterial and anticancer agents: Design, synthesis, and mechanistic investigation of novel 4H-pyran–pyrazole hybrids. Bioorganic Chemistry. 2026;183:110583. doi:10.1016/j.bioorg.2026.110583

BibTeX
@article{Aljohani2026,
  author = {Aljohani, Salwa and Zaki, Sara Alaa Eldin and Alatawi, Asma Obaidallah and Jame, Rasha and Al-Otaibi, Amenah S and AlRashidi, Aljazi Abdullah and Elhenawy, Ahmed A and Eldin, Zienab E and El-Agrody, Ahmed M and Abd El-Mawgoud, Heba K and Elgammal, Walid E},
  title = {Dual-action antibacterial and anticancer agents: Design, synthesis, and mechanistic investigation of novel 4H-pyran–pyrazole hybrids},
  journal = {Bioorganic Chemistry},
  year = {2026},
  volume = {183},
  pages = {110583},
  doi = {10.1016/j.bioorg.2026.110583}
}
Kostenlos starten →